Evaluation of the Absolute Bioavailability and Mass Balance of CHF6001 (Tanimilast) in Healthy Subjects

Clinical trial NCT04756960 · COMPLETED

Trial details

NCT number: NCT04756960
Sponsor: Chiesi Farmaceutici S.p.A.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Chronic Obstructive Pulmonary Disease (COPD)COPD

Start date: 2021-03-10
Primary completion: 2021-04-29
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.